ema bpc 157 approval status The Peptide Reclassification Everyone's Talking About: A Pharmacist's Take on What RFK Jr's Announcement Actually Means BPC-157 Pure Oral Spray,

BPC-157 Pure Oral Spray, .85 Oz (120 sprays) | Dr. Marty Ross, MD

Is there a broader metabolic or hormonal context influencing tissue repair

HomeKits

Size:3 x 20ml

mechanism unexplained Relative contributions of direct peptide effects versus downstream IGF-1 actions inadequately characterized Long-term receptor sensitivity and potential for desensitization inadequately studied Individual patient variability in response not well-characterized Potential for differential effects based on endogenous growth hormone status unclear Long-Term Safety Considerations Critical safety questions remain unanswered regarding chronic peptide administration: Cardiovascular safety concerns – FDA warnings cite risks of increased heart rate, systemic vasodilation, flushing, and transient hypotension Immunogenicity risks – FDA identifies both peptides as potentially immunogenic with risk of serious immune reactions including anaphylaxis Cancer risk – theoretical concern that chronic growth hormone/IGF-1 elevation could promote cellular proliferation